XML 27 R14.htm IDEA: XBRL DOCUMENT

Investment in Marketable Securities	12 Months Ended
Investment in Marketable Securities	Dec. 31, 2017
Investments, All Other Investments [Abstract]
Investment in Marketable Securities	Investment in Marketable Securities Investment in marketable securities of $4,758 and $183,883 at December 31, 2017 and 2016, respectively, consists primarily of preferred and common stock investments in other REITs and certain real estate related bonds which are classified as available-for-sale securities and recorded at fair value. The cost basis net of impairments of available-for-sale securities was $4,482 and $125,311 at December 31, 2017 and 2016, respectively. Unrealized holding gains and losses on available-for-sale securities are excluded from earnings and reported as a separate component of comprehensive income until realized. The Company has net accumulated comprehensive income related to its marketable securities portfolio of $275, $58,572 and $39,113, which includes gross unrealized losses of $72, $598 and $2,242 as of December 31, 2017, 2016 and 2015, respectively. Securities with gross unrealized losses have a related fair value of $3,276 and $1,204 as of December 31, 2017 and 2016, respectively. The Company’s policy for assessing recoverability of its available-for-sale securities is to record a charge against net earnings when the Company determines that a decline in the fair value of a security drops below the cost basis and believes that decline to be other-than-temporary. Factors in the assessment of other-than-temporary impairment include determining whether (1) the Company expects the value of the security to recover, (2) the Company has the ability and intent to hold the security until it recovers, and (3) the length of time and degree to which the security’s price has declined. During the year ended December 31, 2016, an other than temporary impairment to available-for-sale securities of $1,327 was recorded on one security which is included as a component of marketable securities realized gain and (impairment), net on the consolidated statements of operations and comprehensive income (loss). During the years ended December 31, 2017 and 2015, the Company recorded no impairment on available-for-sale securities. Dividend income is recognized when received. During the years ended December 31, 2017, 2016 and 2015, dividend income from marketable securities of $2,857, $10,490 and $10,144 was recognized and is included as a part of continuing operations in interest and dividend income on the consolidated statements of operations and comprehensive income (loss).